Factors influencing adherence to therapeutic regimens among people with Type 2 diabetes mellitus in Yangon, Myanmar

© 2018 Journal of Population and Social Studies [JPSS]. Adherence to therapeutic regimens is a major challenge among people with Type 2 diabetes mellitus to achieve glycemic control. This study aimed to examine the factors influencing adherence to therapeutic regimens among 200 people with Type 2 d...

Full description

Saved in:
Bibliographic Details
Main Authors: Lwe Say Paw Hla, Kanaungnit Pongthavornkamol, Doungrut Wattanakitkrileart, Pisamai Orathai
Other Authors: Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Format: Article
Published: 2019
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/47401
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
Description
Summary:© 2018 Journal of Population and Social Studies [JPSS]. Adherence to therapeutic regimens is a major challenge among people with Type 2 diabetes mellitus to achieve glycemic control. This study aimed to examine the factors influencing adherence to therapeutic regimens among 200 people with Type 2 diabetes at an Outpatient Department in two Yangon General Hospitals. Hierarchical multiple regression analysis showed the participants had good adherence to their therapeutic regimens. However, their adherence to specific diet, physical exercise, and blood glucose monitoring was lower than adherence to medication and foot care. The prevalence of poor glycemic control (71%) was significantly higher in this study. Analysis indicated patients with better family support, good patient-healthcare provider relationship, better self-efficacy and fewer comorbidities were better adhered to therapeutic regimens accounted for 71.9% of the variability in adherence behavior (R2 = 0.719, F (1,194) = 72.98, p < 0.001). Therefore, the study recommends nurses and other healthcare providers consider five predictors to develop effective family-based interventions that empower people with Type 2 diabetes mellitus to improve their adherence to therapeutic regimens.